Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 13, 2026Neurology

Effects of Vitamin D Supplementation on Disease Activity after a Clinically Isolated Syndrome According to Plasma Vitamin D Levels: Ancillary Analysis of the D-lay MS Randomized Controlled Trial (P7-19.005)

View Full Paper
Ask AI
Bookmark
Share

Authors

MRManon RivalCDChristophe DematteïLBLysiane Boulet

Discussion

Loading...

Member takes

Overview

Randomized trial evaluates vitamin D effects on disease activity in individuals with clinically isolated syndrome, suggesting a potential therapeutic role.

Key Points

  • This research aims to assess how increases in plasma vitamin D levels affect disease activity after a clinically isolated syndrome.
  • Participants were part of the D-lay MS Randomized Controlled Trial, focused on vitamin D supplementation.
  • Evaluated disease activity over 24 months, measuring relapses and MRI activity with new or contrast-enhancing lesions.
  • Increased plasma vitamin D levels resulted in a significant reduction in relapse rates.
  • MRI activity showed a decrease in new and contrast-enhancing lesions with higher vitamin D levels.

Cite This Study

Rival et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf32afaef96ed7f055ae2https://doi.org/10.1212/wnl.0000000000216162
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of vitamin D as adjuvant therapy on multiple sclerosis: an updated systematic review and meta-analysis of randomized controlled trials2025
  2. 2Can Vitamin D Reduce Inflammation? The Influence of Supplementation on Selected Immunological Markers2024 · 2 citations
  3. 3VITAMIN D3 IN THE PATHOGENESIS AND CLINICAL COURSE OF MULTIPLE SCLEROSIS: A COMPREHENSIVE REVIEW OF CURRENT EVIDENCE (2015–2026)2026
  4. 4Vitamin D affects the risk of disease activity in multiple sclerosis2024 · 9 citations
  5. 5Can Vitamin D Supplementation Improve Inflammation in Relapsing-Remitting Multiple Sclerosis Patients?2024 · 2 citations